Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
COCH
STRONG SELLEnvoy Medical, Inc. · Healthcare · United States · $51M · Avg Vol: $442K/d
COMPANY DESCRIPTION
Envoy Medical, Inc. is a medical device company focused on developing innovative hearing technologies, including the Esteem fully implanted active middle ear implant and the Acclaim cochlear implant. The company's competitive moat is its advanced, fully implantable technology that utilizes the natural ear to capture sound, offering a distinct lifestyle advantage over external hearing aids. Envoy operates as a specialized niche innovator in the hearing health market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.2M | 0.3M | 0.2M | 0.2M | 0.6% | 0.2M | 0.2M | 0.2M | -0.2% |
| EPS | -0.40 | -0.65 | -0.41 | -0.46 | — | -0.97 | -0.29 | -0.19 | — |
| Shares | 77.0M | 77.0M | 77.0M | 77.0M | 0.0% | 77.0M | — | — | — |
| Debt | 34.5M | 0.6M | 19.7M | 0.9M | -70.1% | 0.9M | — | — | — |
| Equity | -36.2M | -1.8M | -18.8M | -11.8M | — | — | — | — | — |
| Op CF | -8.8M | -17.1M | -17.9M | -18.2M | — | -20.5M | — | — | — |
| Inv CF | -0.2M | -0.2M | -1.0M | -0.2M | — | — | — | — | — |
| Fin CF | 8.1M | 21.3M | 20.2M | 16.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of COCH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| COCH | Envoy Medical, Inc.(you) | $51M | 14 | STRONG SELL |
| LUNG | Pulmonx Corporation | $53M | 17 | STRONG SELL |
| MDAI | Spectral AI, Inc. | $52M | 18 | STRONG SELL |
| ARAY | Accuray Incorporated | $53M | 18 | STRONG SELL |
| LNSR | LENSAR, Inc. | $69M | 11 | STRONG SELL |
| OM | Outset Medical, Inc. | $75M | 15 | STRONG SELL |
| ELUT | Elutia Inc. | $51M | 23 | SELL |
| ECOR | electroCore, Inc. | $51M | 24 | SELL |
| HYPR | Hyperfine, Inc. | $95M | 13 | STRONG SELL |
| SERA | Sera Prognostics, Inc. | $80M | 5 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.7%